L
Lineage Cell Therapeutics Inc
F:BT3
Lineage Cell Therapeutics Inc
F:BT3
Price:
1.076
EUR
7.17%
Market Closed
Market Cap:
€203.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
N
|
Nine Dragons Paper (Holdings) Ltd
XMUN:N3Y
|
HK |
|
Logan Energy Corp
F:R76
|
CA |
|
G
|
General Mills Inc
F:GRM
|
US |
|
Majestic Corporation PLC
OTC:MCJCF
|
UK |
|
Sandvik AB
F:SVKB
|
SE |
|
Komatsu Ltd
F:KOM1
|
JP |
|
Solstad Maritime ASA
F:O6O
|
NO |
|
First Commonwealth Financial Corp
NYSE:FCF
|
US |
|
D
|
Dechra Pharmaceuticals PLC
SWB:1PK
|
UK |
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
T
|
TotalEnergies SE
DUS:TOTB
|
FR |
|
Deutsche Post AG
F:DHL
|
DE |
|
I
|
IN8BIO, Inc.
NASDAQ:INAB
|
US |
|
Claros Mortgage Trust Inc
F:5WO
|
US |
|
A
|
Abbott Laboratories
SWB:ABL
|
US |
|
Koninklijke Philips NV
LSE:0A2M
|
NL |
|
V
|
VGI PCL
SET:VGI
|
TH |
DCF Valuation
is not available for Lineage Cell Therapeutics Inc
is not available for Lineage Cell Therapeutics Inc
BT3's DCF value cannot be reliably calculated.
Switch to
See Also
Other Lineage Cell Therapeutics Inc listings:
Discover More
